CTRI/2020/07/026420
Not yet recruiting
Phase 2
Clinical study of Taqashshur-al-jild (psoriasis) with Therapeutic evaluation of Unani drugs Aftimoon (Cuscuta reflexa) with Ma ul Jubn (whey) as Joshanda (Decoction) and Magh Tukhmi Kharpaza (seed of kernel of musk melon) along with Gule Baboona (Matriucccaria chamomillia) as Zimad (paste) in its Management
central counsal for research in unani medicine new delhi0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: L409- Psoriasis, unspecified
- Sponsor
- central counsal for research in unani medicine new delhi
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinically Diagnosed Patients of Psoriasis.
- •Patients irrespective of gender.
- •Patients in the age group of 10\-60 years.
- •Clinically stable patients.
- •Patients who have agreed to sign the informed consent form and follow up the protocol.
Exclusion Criteria
- •Subjects below the age group of 10 and above the age of 60 years.
- •Patients suffering from from other concomitant disorders like Dermatophytes,Eczema ,Seborrhic Dermatitis,Pityriasis Rosea.
- •Patients with systemic diseases like diabetes,malignancy.
- •patients who refuse to give written consent for the study.
- •pregnant and lactating women.
- •any of them not covered under inclusion criteria.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To study the predominance of ekakustha(psoriasis) in prespective to deha pakritiCTRI/2022/01/039547Shri NPA Govt Ayurved college Raipur Chhattisgarh
Recruiting
Phase 1
TCM syndrome study of psoriasis vulgaris based on intestinal microfloraITMCTR1900002445Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Completed
Phase 2
A clinical trail to study the effects, safety and efficacy of Polyherbal formulations in patients with mild to moderate psoriasisCTRI/2010/091/000594APMC college pf pharmaceutical education & Research, Himatnagar20
Unknown
Phase 3
A Phase 3 Clinical Study of KHK4827JPRN-jRCT2080222010Kyowa Hakko Kirin Co., Ltd.100
Completed
Not Applicable
Clinical study of a new skin diseasehemangiomaJPRN-UMIN000030813Gunma university1,600